查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
周邊血管器械市場規模、佔有率及成長分析（按類型、應用、最終用戶和地區分類）－2026-2033年產業預測
市場調查報告書
商品編碼
1899562

周邊血管器械市場規模、佔有率及成長分析（按類型、應用、最終用戶和地區分類）－2026-2033年產業預測

Peripheral Vascular Devices Market Size, Share, and Growth Analysis, By Type (Peripheral Stents, PTA Balloons), By Application (Peripheral Arterial Disease (PAD), Aneurysms), By End-Use, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年，周邊血管器械市場規模將達到 89.6 億美元，到 2025 年將達到 94.5 億美元，到 2033 年將達到 145.1 億美元，預測期（2026-2033 年）的複合年成長率為 5.5%。

由於血管疾病發生率上升和人口老化加劇，周邊血管器械市場正經歷強勁成長。創新型器械對於這些疾病的診斷和治療至關重要，它們能夠實現血管成形術和置入術等微創手術，加速患者康復並提高患者舒適度。糖尿病和肥胖等文明病的增加也進一步推動了對有效治療方案的需求。診斷影像技術的進步和有利的報銷政策正在促進市場擴張。然而，嚴格的監管要求、新興國家的高成本以及熟練專業人員短缺等挑戰可能會阻礙市場成長。關鍵趨勢包括藥物釋放型球囊、生物可吸收支架和個人化醫療的出現，以及數位健康技術在改善患者預後的應用。

周邊血管器械市場促進因素

心血管疾病，尤其是周邊動脈疾病（PAD）和深層靜脈栓塞症（DVT）的發生率不斷上升，顯著推動了周邊血管器械市場的成長。心血管疾病是全球主要的死亡原因之一，這表明對有效的診斷和治療方案的需求日益成長。隨著醫療保健系統面臨這一日益嚴峻的挑戰，作為疾病管理關鍵組成部分的周邊血管器械的需求持續成長。對高效治療和改善患者預後的迫切需求，正在推動市場創新和擴張，並進一步影響其整體成長軌跡。

周邊血管器械市場的限制因素

由於周邊血管器械產品高成本，該市場面臨許多限制因素。這些高昂的成本源自於多種因素，包括大規模的研發投入、嚴格的監管要求以及先進材料和技術的應用。因此，高昂的價格分佈可能會阻礙這些器械的廣泛應用，尤其是在醫療預算有限、報銷體係不完善的發展中地區。這些經濟障礙可能會阻礙重要醫療技術的普及，並最終影響到有需要的患者的治療選擇。

周邊血管器械市場趨勢

周邊血管介入器械市場正呈現藥物釋放型器械應用日益普及的趨勢，這類器械在預防血管再阻塞發揮關鍵作用，從而改善患者預後。這些先進的器械旨在將標靶治療藥物直接輸送到受影響的血管，有效降低血管再阻塞的風險和再次手術的需求。透過使用抗增殖藥物（例如藥物釋放型支架中所含的藥物），這些產品能夠顯著減少動脈內瘢痕組織的形成，從而提高血管內治療的長期成功率。這一趨勢凸顯了血管治療領域向創新和以患者為中心的解決方案轉變的趨勢，也反映了對改善臨床療效的承諾。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數（2025）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 監管環境
  • 專利分析

全球周邊血管器械市場規模（按類型和複合年成長率分類）（2026-2033 年）

  • 外周支架
  • PTA氣球
  • 栓塞保護裝置
  • 主動脈支架
  • 人工外科移植
  • 慢性完全閉塞治療裝置
  • 其他

全球周邊血管器械市場規模（按應用領域分類）及複合年成長率（2026-2033 年）

  • 周邊動脈疾病（PAD）
  • 動脈瘤
  • 靜脈疾病

全球周邊血管器械市場規模（依最終用途分類）及複合年成長率（2026-2033 年）

  • 醫院
  • 門診手術中心（ASC）
  • 專科診所
  • 其他

全球周邊血管器械市場規模及複合年成長率（2026-2033）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2025 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2025 年）
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Medtronic plc（USA）
  • Boston Scientific Corporation（USA）
  • Abbott Laboratories（USA）
  • Becton, Dickinson and Company（USA）
  • Koninklijke Philips NV（Netherlands）
  • Cook Medical Inc.（USA）
  • Terumo Corporation（Japan）
  • Cardinal Health, Inc.（USA）
  • B. Braun Melsungen AG（Germany）
  • BIOTRONIK SE & Co. KG（Germany）
  • WL Gore & Associates, Inc.（USA）
  • Getinge AB（Sweden）
  • MicroPort Scientific Corporation（China）
  • CryoLife, Inc.（USA）
  • Lombard Medical（UK）
  • Merit Medical Systems, Inc.（USA）
  • Edwards Lifesciences Corporation（USA）
  • Nipro Corporation（Japan）
  • Bluesail Medical Co., Ltd.（China）

結論與建議

簡介目錄
Product Code: SQMIG35A2529

Peripheral Vascular Devices Market size was valued at USD 8.96 Billion in 2024 and is poised to grow from USD 9.45 Billion in 2025 to USD 14.51 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The Peripheral Vascular Devices market is experiencing robust growth driven by the rising prevalence of vascular diseases and an aging population. Innovative devices are essential for diagnosing and treating these conditions, enabling minimally invasive procedures like angioplasty and stenting, which enhance recovery and patient comfort. The increasing incidence of lifestyle-related illnesses, such as diabetes and obesity, further propels demand for effective treatment solutions. Technological advancements in imaging, coupled with favorable reimbursement policies, support market expansion. However, challenges such as stringent regulatory requirements, high costs in emerging economies, and a shortage of skilled professionals may impede growth. Key trends include the emergence of drug-coated balloons, bioresorbable stents, and personalized medicine, along with the integration of digital health technologies to enhance patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Vascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Vascular Devices Market Segments Analysis

Global Peripheral Vascular Devices Market is segmented by Type, Application, End-Use and region. Based on Type, the market is segmented into Peripheral Stents, PTA Balloons,embolic protection devices, Aortic Stents, Synthetic Surgical Grafts, Chronic Total Occlusion Devices and Others. Based on Application, the market is segmented into Peripheral Arterial Disease (PAD), Aneurysms and Venous Diseases. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Vascular Devices Market

The increasing incidence of cardiovascular conditions, particularly peripheral artery disease (PAD) and deep vein thrombosis (DVT), significantly propels the growth of the peripheral vascular devices market. Cardiovascular diseases are recognized globally as a major cause of mortality, which underscores the heightened necessity for effective diagnostic and therapeutic solutions. As healthcare systems confront this escalating challenge, the demand for peripheral vascular devices continues to rise as a vital component in managing these conditions. The urgency to provide efficient treatments and improve patient outcomes drives innovation and expansion within the market, further influencing its overall growth trajectory.

Restraints in the Peripheral Vascular Devices Market

The peripheral vascular devices market faces a notable constraint due to the elevated costs linked to these products. This expense arises from various factors, including extensive research and development efforts, stringent regulatory compliance, and the incorporation of advanced materials and technologies. As a result, the high price point can hinder the widespread adoption of these devices, especially in developing regions where healthcare budgets are constrained and reimbursement is difficult to navigate. Consequently, such financial barriers may prevent access to these crucial medical advancements, ultimately impacting treatment options for patients in need.

Market Trends of the Peripheral Vascular Devices Market

The peripheral vascular devices market is witnessing an increasing inclination towards drug-eluting devices, which play a crucial role in enhancing patient outcomes by preventing restenosis. These advanced devices are engineered to deliver targeted therapeutic agents directly to affected blood vessels, effectively minimizing the risk of re-narrowing and the necessity for repeat procedures. By employing anti-proliferative drugs, such as those found in drug-eluting stents, these products significantly reduce scar tissue formation within arteries, thereby improving the long-term success rates of vascular interventions. This trend underscores a broader shift towards innovation and patient-centric solutions in vascular care, demonstrating a commitment to better clinical results.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis

Global Peripheral Vascular Devices Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Peripheral Stents
  • PTA Balloons
  • Embolic Protection Devices
  • Aortic Stents
  • Synthetic Surgical Grafts
  • Chronic Total Occlusion Devices
  • Others

Global Peripheral Vascular Devices Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Peripheral Arterial Disease (PAD)
  • Aneurysms
  • Venous Diseases

Global Peripheral Vascular Devices Market Size by End-Use & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Others

Global Peripheral Vascular Devices Market Size & CAGR (2026-2033)

  • North America (Type, Application, End-Use)
    • US
    • Canada
  • Europe (Type, Application, End-Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Application, End-Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Application, End-Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Application, End-Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic plc (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • W. L. Gore & Associates, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CryoLife, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lombard Medical (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bluesail Medical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations